Price movement over the last 24 hours
ABM Investama Tbk vs Diagnos Laboratorium Utama Tbk. — how do they compare? ABM Investama Tbk trades at Rp2,290 (market cap 6.3T, 238.5K 24h volume), while Diagnos Laboratorium Utama Tbk. trades at Rp232 (market cap 319B, 1.74M 24h volume). The key difference: ABM Investama Tbk is far larger — about 19.7× Diagnos Laboratorium Utama Tbk.'s market cap, and Diagnos Laboratorium Utama Tbk. is more actively traded (1.74M versus 238.5K). Which is the better fit depends on your goals.
| ABMM | DGNS | |
|---|---|---|
Market Cap | 6.3T | 319B |
Volume | 238.5K | 1.74M |
Lot | 2.39K | 17.44K |
Turnover | 547.11M | 400.92M |
Average Price | 2,293.95 | 229.87 |
Value | 547.11M | 400.92M |
Indicative Equilibrium Price | 2,290 | 232 |
Indicative Equilibrium Volume | 29 | 212 |
Trailing returns across standard periods
Latest headlines on both assets
ABM Investama, PT (the company) was established under its original name of PT Adiratna Bani Makmur on Jun 1, 2006 then changed to PT ABM Investama Tbk based on Notaries Deed dated Aug 31, 2009. The deed of establishment was approved by the the Ministry of Justice dated Oct 16, 2009. The Company’s articles of association has been amended several times, most recently by notarial deed No. 163 of Mrs. Aulia Taufani, S.H., dated Jul 21, 2011, concerning among others, public offering of stock.
Read more on ABMM →PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →